SILO·82711P201·US·equity·Healthcare - Biotechnology-13D/G
SILO (SILO PHARMA INC) is held by 9 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($64,756), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($22,587), JANE STREET GROUP, LLC ($16,101). Net institutional sentiment: Mixed.
See how SILO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer